BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10951159)

  • 41. Intra-uterine parvovirus B19 infection and meconium peritonitis.
    Zerbini M; Gentilomi GA; Gallinella G; Morandi R; Calvi S; Guerra B; Musiani M
    Prenat Diagn; 1998 Jun; 18(6):599-606. PubMed ID: 9664606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parvovirus B19 infection in pregnancy.
    de Jong EP; de Haan TR; Kroes AC; Beersma MF; Oepkes D; Walther FJ
    J Clin Virol; 2006 May; 36(1):1-7. PubMed ID: 16488187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prenatal parvovirus B19 infection in fetus].
    L'ubuský M; Pospísilová D; Hyjánek J; Procházka M; Mícková I
    Ceska Gynekol; 2005 Jul; 70(4):306-11. PubMed ID: 16128133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Parvovirus B19 infection in pregnancy].
    Jensen IP; Heegaard ED
    Ugeskr Laeger; 2003 Nov; 165(46):4394-7. PubMed ID: 14655561
    [No Abstract]   [Full Text] [Related]  

  • 45. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis.
    Yaegashi N; Niinuma T; Chisaka H; Watanabe T; Uehara S; Okamura K; Moffatt S; Sugamura K; Yajima A
    J Infect; 1998 Jul; 37(1):28-35. PubMed ID: 9733374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
    Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
    J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [NEW APPROACH IN DIAGNOSTIC ALGORITHM OF AN INFECTIOUS AGENTS (PARVOVIRUS B19 AND CHLAMYDIA TRACHOMATIS) INVOLVED IN THE DEVELOPMENT OF PATHOLOGICAL PREGNANCY].
    Voleva S; Ivanova S; Marinov B; Genova-Kalou P; Manolov V; Vasilev V
    Akush Ginekol (Sofiia); 2016; 55(3):30-9. PubMed ID: 27514136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A neonate with subumbilical swellings].
    van Beers-Tas MH; Heidema J; van Dongen-van Baal M
    Ned Tijdschr Geneeskd; 2012; 156(44):A4084. PubMed ID: 23114168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fetal Parvowirus B19 infection with hydrops fetalis, a case report].
    Engel K; Grabarczyk P; Celewicz Z; Grzymała-Figura A; Wegrzynowski J; Brojer E
    Ginekol Pol; 2012 Feb; 83(2):141-4. PubMed ID: 22568361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A case report.
    Plachouras N; Stefanidis K; Andronikou S; Lolis D
    J Reprod Med; 1999 Apr; 44(4):377-80. PubMed ID: 10319311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
    Enders M; Weidner A; Zoellner I; Searle K; Enders G
    Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parvovirus B19 infection in pregnancy.
    Crane J; Mundle W; Boucoiran I;
    J Obstet Gynaecol Can; 2014 Dec; 36(12):1107-1116. PubMed ID: 25668048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
    Vyse AJ; Andrews NJ; Hesketh LM; Pebody R
    Epidemiol Infect; 2007 Nov; 135(8):1354-62. PubMed ID: 17291377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen.
    Venturoli S; Gallinella G; Manaresi E; Gentilomi G; Musiani M; Zerbini M
    J Infect Dis; 1998 Dec; 178(6):1826-9. PubMed ID: 9815244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Which supervision and treatment to use in case of exposure to Parvovirus B19 during pregnancy?].
    Brochot C; Debever P; Subtil D; Puech F
    Gynecol Obstet Fertil; 2008 Feb; 36(2):204-211. PubMed ID: 18262817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Parvovirus B19 in pregnancy: literature review].
    Morel O; Chagnaud S; Laperrelle J; Clément D; Malartic C; Akerman G; Tulpin L; Sitbon M; Barranger E
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1095-104. PubMed ID: 18006356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serological and virological analysis of maternal and fetal blood samples in prenatal human parvovirus b19 infection.
    Weiffenbach J; Bald R; Gloning KP; Minderer S; Gärtner BC; Weidner A; Hanke M; Enders M
    J Infect Dis; 2012 Mar; 205(5):782-8. PubMed ID: 22275404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B19 parvovirus-induced fetal hydrops:good outcome after intrauterine blood transfusion at 18 weeks of gestation.
    Bousquet F; Segondy M; Faure JM; Deschamps F; Boulot P
    Fetal Diagn Ther; 2000; 15(3):132-3. PubMed ID: 10781995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection.
    Yaegashi N
    Tohoku J Exp Med; 2000 Feb; 190(2):65-82. PubMed ID: 10770616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection.
    Pryde PG; Nugent CE; Pridjian G; Barr M; Faix RG
    Obstet Gynecol; 1992 May; 79(5 ( Pt 2)):859-61. PubMed ID: 1314362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.